ArticleCancer gene therapy2023

Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c.

Jian Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.